All coverage
Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company specializing in RNA interference therapies for cancer. The company was co-founded by Nobel laureate Dr. Craig…
Earnings Release: On November 3, 2025, ON Semiconductor announced its third-quarter 2025 financial results, which were better than expected. The company reported Q3 revenue…
UniQure’s stock has been on a wild ride in 2025. After starting the year in the mid-teens, QURE shares skyrocketed through mid-2025 on hopes…
MongoDB’s announcement on November 3, 2025 signaled a major leadership shake-up for the $29 billion database company. Dev Ittycheria, who has served as CEO…
Pfizer’s stock has languished in 2025 despite a rising broader market. At ~$24.65, PFE is roughly flat since January and far below its 2021…
Amazon’s stock is riding high after its latest earnings triumph. Shares of AMZN skyrocketed ~10% on Friday, Oct. 31 following the Q3 report, pushing…
Opendoor’s stock has experienced a jaw-dropping rally in 2025, transforming from a penny-stock into a retail trading sensation. After languishing below $1 per share…
Acrivon Therapeutics is a Boston-area biotech founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicinestockanalysis.com. The company’s name “Acrivon”…
NIO’s stock has been on a notable upswing heading into November 2025. Shares closed at $7.25 on October 31, 2025 – a multi-month high…
TGE’s stock has experienced a rollercoaster in recent days, capturing investors’ attention. In the final week of October 2025, shares entered a freefall: between…
IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and water…
Rani Therapeutics’ stock price has been on a tear in late 2025, turning heads in the biotech investing community. After languishing under $1 for…
In short: MSP Recovery’s stock is trading at mere pennies after a spectacular rise-and-fall on Nov 3. The company is fighting for survival –…
Dell Technologies stock is trading around $162 per share as of Nov. 3, 2025, near its 52-week high after a massive rally fueled by…
Sources: Financial data from Yahoo Finance/Refinitivreuters.comreuters.com and company filings; GlobeNewswire press releaseglobenewswire.comglobenewswire.com; Reuters news reportreuters.com; Bernama interview with CEObernama.combernama.com; Stock analysis sites and SEC…
Berkshire Hathaway’s Class B stock trades around $477–$480 as of early November 2025stockinvest.us. The share price has eased off about 5% since mid-October, when…
